Trials / Completed
CompletedNCT05274685
Early Renal Replacement Therapy in COVID 19 Patients With AKI Does it Improve the Outcome?
Early Renal Replacement Therapy in COVID 19 Patients With AKI Improves the Prognosis of the Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
patients will be divided into two equal groups, each group including 50 adult patients with a confirmed diagnosis of covid, patients with acute kidney injury, the first group will be treated with early hemodialysis, second group will be conservative until there is an urgent need for dialysis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | haemodialysis | continuous venovenous hemodiafiltration (CVVHDF) at a prescribed dose of 30-35 mL/kg/h of effluent and with regional citrate anticoagulation |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2021-12-01
- Completion
- 2022-01-01
- First posted
- 2022-03-10
- Last updated
- 2022-03-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05274685. Inclusion in this directory is not an endorsement.